scispace - formally typeset
G

Glòria Garrabou

Researcher at Health Science University

Publications -  112
Citations -  2670

Glòria Garrabou is an academic researcher from Health Science University. The author has contributed to research in topics: Mitochondrial toxicity & Mitochondrion. The author has an hindex of 22, co-authored 91 publications receiving 2197 citations. Previous affiliations of Glòria Garrabou include University of Barcelona & Carlos III Health Institute.

Papers
More filters
Journal ArticleDOI

Noninvasive Diagnosis of Mitochondrial Dysfunction in HAART-Related Hyperlactatemia

TL;DR: Developed welfare states facilitate women’s access into the labor force but not into powerful and desirable positions, and nations characterized by progressive and developed welfare policies and by a large public service sector tend to have high levels of female labor force participation, along with a high concentration of women in female‐typed occupations and low female representation in managerial occupations.
Journal ArticleDOI

Fibroblast growth factor 21 protects the heart from oxidative stress

TL;DR: Fgf21 acts as an antioxidant factor in the heart, preventing induction of pro-oxidative pathways by inflammatory or hypertrophic conditions, and regulates genes involved in antioxidant pathways in an autocrine manner, thus preventing ROS production in cardiac cells.
Journal ArticleDOI

The Effects of Sepsis on Mitochondria

TL;DR: A plasmatic factor such as nitric oxide, increased in inflammation and able to induce mitochondrial dysfunction, oxidative stress and apoptosis, may be responsible for cell damage in sepsis.
Journal ArticleDOI

Reversible Inhibition of Mitochondrial Protein Synthesis during Linezolid-Related Hyperlactatemia

TL;DR: Linezolid inhibits mitochondrial protein synthesis, leading to decreased mitochondrial enzymatic activity, which causes linezolid-related hyperlactatemia, which resolves upon discontinuation of lineZolid treatment.